Castle Biosciences, Inc. (NASDAQ: CSTL)
$26.8000
+0.3000 ( +1.17% ) 96.6K
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
Market Data
Open
$26.8000
Previous close
$26.5000
Volume
96.6K
Market cap
$742.19M
Day range
$25.7420 - $27.0440
52 week range
$16.9650 - $35.8400
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| def | Proxies and info statements | 55 | Apr 10, 2024 |
| ars | Annual reports | 1 | Apr 10, 2024 |
| 4 | Insider transactions | 1 | Apr 10, 2024 |
| 4 | Insider transactions | 1 | Apr 08, 2024 |
| 4 | Insider transactions | 1 | Apr 05, 2024 |
| 4 | Insider transactions | 1 | Mar 28, 2024 |
| 3 | Insider transactions | 2 | Mar 28, 2024 |
| 8-k | 8K-related | 14 | Mar 27, 2024 |
| 4 | Insider transactions | 1 | Mar 22, 2024 |
| 4 | Insider transactions | 1 | Mar 11, 2024 |